SPX3,655.04-38.19 -1.03%
DIA292.72-3.14 -1.06%
IXIC10,802.92-65.00 -0.60%

BRIEF-Eton Pharmaceuticals Announces Acquisition Of FDA-Approved Rare Disease Product

BRIEF-Eton Pharmaceuticals Announces Acquisition Of FDA-Approved Rare Disease Product

Reuters · 09/13/2022 09:32
BRIEF-Eton Pharmaceuticals Announces Acquisition Of FDA-Approved Rare Disease Product

- Eton Pharmaceuticals Inc ETON.O:

  • ETON PHARMACEUTICALS ANNOUNCES ACQUISITION OF FDA-APPROVED RARE DISEASE PRODUCT, BETAINE ANHYDROUS FOR ORAL SOLUTION

  • ETON PHARMACEUTICALS INC - EXPECT TRANSACTION TO BE ACCRETIVE TO 2023 EARNINGS

Source text for Eikon: ID:

Further company coverage: ETON.O


((reuters.briefs@thomsonreuters.com;))